1005-2194
2014 Issue 2
Prospective of hematopoietic stem cell transplantation
HUANG Xiao-jun;Peking University People’s Hospital;Peking University Institute of Hematology;Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation;Life Science United Center of Peking University and Tsinghua University;
HUANG Xiao-jun;Peking University People’s Hospital;Peking University Institute of Hematology;Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation;Life Science United Center of Peking University and Tsinghua University;
..............page:97-100
Progress in unrelated and haploidentical donor hematopoietic stem cell transplantation: improvement of transplantation model and the latest clinical efficacy
LIU Dai-hong;Peking University People’s Hospital;Peking University Institute of Hematology;
LIU Dai-hong;Peking University People’s Hospital;Peking University Institute of Hematology;
..............page:101-105
The progress in preconditioning regimens in allogeneic HSCT
WANG Jian-min;Department of Hematology;Changhai Hospital;Second Medical University of PLA;
WANG Jian-min;Department of Hematology;Changhai Hospital;Second Medical University of PLA;
..............page:106-110
Quality of life assessment in long-term survivors after haematopoietic stem cell transplantation
LIU Li-min;WU De-pei;The First Affiliated Hospital of Soochow University;Jiangsu Institute of Hematology;Key laboratory of Thrombosis and Hemostasis of Ministry of Health;
LIU Li-min;WU De-pei;The First Affiliated Hospital of Soochow University;Jiangsu Institute of Hematology;Key laboratory of Thrombosis and Hemostasis of Ministry of Health;
..............page:111-114
..............page:114
Several issues concerning hematopoietic stem cell transplantation in treatment of multiple myeloma in the new-drug era
LI Rong;HOU Jian;Department of Hematology;Shanghai Changzheng Hospital;
LI Rong;HOU Jian;Department of Hematology;Shanghai Changzheng Hospital;
..............page:115-117+126
Hematopoietic stem cell transplantation in non-Hodgkin lymphoma
SONG Yong-ping;ZHOU Ke-shu;The Affiliated Cancer Hospital of Zhengzhou university;
SONG Yong-ping;ZHOU Ke-shu;The Affiliated Cancer Hospital of Zhengzhou university;
..............page:118-121
Prevention and treatment strategy on hematologic malignancy relapse after allogeneic hematopoietic stem cell transplantation
HUANG He;Center of Bone Marrow Transplantation;the First Affiliated Hospital of Zhejiang University Medical College;
HUANG He;Center of Bone Marrow Transplantation;the First Affiliated Hospital of Zhejiang University Medical College;
..............page:122-126
Advance in umbilical cord blood hematopoietic stem cell transplantation
SUN Zi-min;Anhui Provincial Hospital;the Affiliated Provincial Hospital of Anhui Medical University;
SUN Zi-min;Anhui Provincial Hospital;the Affiliated Provincial Hospital of Anhui Medical University;
..............page:127-131
..............page:131
The dignosis and treatment of graft-versus-host disease
LIU Ting;Department of Hematology;West China Hospital of Sichuan University;
LIU Ting;Department of Hematology;West China Hospital of Sichuan University;
..............page:132-136
Emphasis on viral infection after hematopoietic stem cell transplantation
LIN Ren;LIU Qi-fa;Department of Hematology;Nanfang Hospital;Southern Medical University;
LIN Ren;LIU Qi-fa;Department of Hematology;Nanfang Hospital;Southern Medical University;
..............page:137-141
Management of central nervous system complications after haematopoietic stem cell transplantation
ZHANG Xiao-hui;Peking University People’s Hospital;Peking University Institute of Hematology;
ZHANG Xiao-hui;Peking University People’s Hospital;Peking University Institute of Hematology;
..............page:142-145
Treatment of post-transplant lymphoproliferative diseases
HUANG Yong;HAN Ming-zhe;Institute of Hematology & Blood Diseases Hospital;Chinese Academy of Medical Science & Peking Union Medical College;
HUANG Yong;HAN Ming-zhe;Institute of Hematology & Blood Diseases Hospital;Chinese Academy of Medical Science & Peking Union Medical College;
..............page:146-149
Diagnosis and treatment of haemorrhagic cystitis after hematopoietic stem cell transplantation
HU Liang-ding;Department of Hematopoietic Stem Cell Transplantation;the 307 Hospital of Chinese PLA;PLA Institute of Hematopoietic Stem Cells;
HU Liang-ding;Department of Hematopoietic Stem Cell Transplantation;the 307 Hospital of Chinese PLA;PLA Institute of Hematopoietic Stem Cells;
..............page:150-151
gan zang yan zheng ji qi fang zhi zhuan jia gong shi
wang yu ming ; yu le cheng ;
wang yu ming ; yu le cheng ;
..............page:152-162
yi xing gan yan bing du xiang guan gan ying hua de lin chuang zhen duan ping gu he kang bing du zhi liao de zong he guan li
ke ji bu shi er wu zhong da zhuan xiang lian he ke ti zu zhuan jia ;
ke ji bu shi er wu zhong da zhuan xiang lian he ke ti zu zhuan jia ;
..............page:163-173
Interpretation of clinical guidelines on treatment of obstructive sleep apnea syndrome
WANG Wei;Respiratory Department;the First Affiliated Hospital of China Medical University;
WANG Wei;Respiratory Department;the First Affiliated Hospital of China Medical University;
..............page:174-176
Clinical value of sepsis biomarkers
XIE Li-xin;Department of Respiratory Medicine;PLA General Hospital;
XIE Li-xin;Department of Respiratory Medicine;PLA General Hospital;
..............page:177-179
Interpretation of clinical research on clopidogrel and aspirin versus aspirin alone for the treatment of high-risk patients with acute non-disabling cerebrovascular event
WANG Yi-long;MENG Xia;ZHAO Xing-quan;WANG Yong-jun;Department of Neurology;Beijing Tiantan Hospital Affiliated to Capital Medical University;
WANG Yi-long;MENG Xia;ZHAO Xing-quan;WANG Yong-jun;Department of Neurology;Beijing Tiantan Hospital Affiliated to Capital Medical University;
..............page:180-182
Unfavorable prognosis of cancer-associated acute pulmonary thromboembolism with sequential anticoagulation
LIU Fan;ZHU Ran;KANG Jian;Institute of Respiratory Disease;First Affiliated Hospital;China Medical University;
LIU Fan;ZHU Ran;KANG Jian;Institute of Respiratory Disease;First Affiliated Hospital;China Medical University;
..............page:183-186
..............page:186
Prognostic significance of immunohistochemical markers in patients with diffuse large B-cell lymphoma and the impact of rituximab on the markers
LI Yan;YANG Ming-zhen;Internal Unit of Haematology Department;the First Affiliated Hospital of Anhui Medical University;
LI Yan;YANG Ming-zhen;Internal Unit of Haematology Department;the First Affiliated Hospital of Anhui Medical University;
..............page:187-190
Clinical value of color doppler in assessment of pulmonary artery pressure in patients with acute massive pulmonary embolism
ZHOU Wei-wei;QI Miao;YUAN Wei;ZHAO Rui;LI Jin-jin;LIU Nan-nan;LIU Cong;ZHANG Yun;Department of Special Diagnosis;Shenyang Military General Hospital;
ZHOU Wei-wei;QI Miao;YUAN Wei;ZHAO Rui;LI Jin-jin;LIU Nan-nan;LIU Cong;ZHANG Yun;Department of Special Diagnosis;Shenyang Military General Hospital;
..............page:191-193
The change of Treg cells and its relationship with chemoresponse and tumor burden during bortezomib based chemotherapy for multiple myeloma
XING Jian;LU Guang;LIU Guo-qiang;XU Min;LU Xi-jing;ZHAO Xia;HAN Fang;WANG Liang;SHANG Ying-hui;DING Hui-fang;Department of Hematology;Shengli Oilfield Central Hospital;
XING Jian;LU Guang;LIU Guo-qiang;XU Min;LU Xi-jing;ZHAO Xia;HAN Fang;WANG Liang;SHANG Ying-hui;DING Hui-fang;Department of Hematology;Shengli Oilfield Central Hospital;
..............page:194-197
Effects of hemodialysis adequacy improvement on dosage of recombinant human erythropoietin in dialysis patients
LIANG Xian-hui;WANG Pei;LIU Zhang-suo;
LIANG Xian-hui;WANG Pei;LIU Zhang-suo;
..............page:198-199
Analysis on risk factors of hyperosmolar state complicated in acute stroke patients
TANG Yong-guo;SONG Shui-jiang;
TANG Yong-guo;SONG Shui-jiang;
..............page:199-200
The study of pramipexole and Sertraline for the treatmentin elderly patients with Parkinson’s disease complicated with depression
BAI Fu-sheng;YOU Lin;XIE Xin;
BAI Fu-sheng;YOU Lin;XIE Xin;
..............page:201-202
Progress in targeted therapy for diffuse large b-cell lymphoma based on regulation and control of cell signal pathway
XUE Wen;ZHAO Wei-li;
XUE Wen;ZHAO Wei-li;
..............page:203-205
Influences of renin-angiotensin system inhibitors on acute renal injury and type Ⅰ cardiorenal syndrome after heart surgery
XU Jia-qi;LIANG Xin-ling;
XU Jia-qi;LIANG Xin-ling;
..............page:206-208
..............page:208
Advance in causes of thrombosis with stents
DAI Jing;L Shu-zheng;SONG Xian-tao;
DAI Jing;L Shu-zheng;SONG Xian-tao;
..............page:209-210
One case report of pleural adenoidcystic carcinoma
ZHOU Mei;ZHANG Jian-chu;YANG Wei-bing;
ZHOU Mei;ZHANG Jian-chu;YANG Wei-bing;
..............page:211-212
One case report of autoimmune myopathy with hepatitis B cirrhosis
WU Jing;LING Ning;ZHOU Zhi;
WU Jing;LING Ning;ZHOU Zhi;
..............page:213-214
Hyperthyroidism complicated with primary hyperparathyroidism: a case report patient
WANG Shun-yu;LI Dan-qing;SU Ben-li;
WANG Shun-yu;LI Dan-qing;SU Ben-li;
..............page:215-216